DCGI grants emergency use authorisation to Corbevax for 12-18 year age group

This approval for Corbevax is likely to speed up the ongoing vaccination drive for children between 15 and 18 years of age, and also for those between 12 and 14 years of age. However, the approval is subject to certain conditions.

Related Keywords

India ,New Delhi ,Delhi ,Bharat ,Zydus Cadilla ,Health Ministry ,Expert Committee On ,Drugs Controller General ,Subject Expert Committee ,Ahmedabad Based Zydus ,Angiotensin Converting ,Corbevax ,Covid 19 ,Covid 19 Vaccine ,Coronavirus ,Corona Vaccines ,Covid Vaccines For Children ,Covid 19 Vaccines For Children ,Covid 19 Vaccines ,